Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

NovaBridge Biosciences (NBP) Equity Ratio (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Equity Ratio data on record, last reported at 0.89 in Q4 2025.

  • On a quarterly basis, Equity Ratio fell 6.28% to 0.89 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.89, a 6.28% decrease, with the full-year FY2025 number at 0.89, down 6.28% from a year prior.
  • Equity Ratio reached 0.89 in Q4 2025 per NBP's latest filing, down from 0.93 in the prior quarter.
  • Over the last five years, Equity Ratio for NBP hit a ceiling of 0.95 in Q2 2025 and a floor of 0.66 in Q4 2023.
  • A 5-year average of 0.85 and a median of 0.89 in 2021 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: dropped 13.4% in 2023, then soared 43.84% in 2024.
  • Tracing NBP's Equity Ratio over 5 years: stood at 0.81 in 2021, then fell by 12.25% to 0.71 in 2022, then dropped by 7.95% to 0.66 in 2023, then skyrocketed by 43.84% to 0.95 in 2024, then fell by 6.28% to 0.89 in 2025.
  • Business Quant data shows Equity Ratio for NBP at 0.89 in Q4 2025, 0.93 in Q3 2025, and 0.95 in Q2 2025.